Search earnings tickers

REGN

2026Q1BMO

Regeneron Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2026-04-29 · Fiscal end 2026-03-31 · Features as of 2026-04-28

← Earnings history

Street

Consensus EPS8.90

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.8%

IV front—

P/C full—

P/C front—

Features as of2026-04-28

Run-up

Close—

Ret 5d-2.1%

Ret 10d-3.1%

Ret 20d-2.3%

Ret 30d-3.3%

Print

Actual EPS

9.47Beat

Estimated EPS8.90

Actual revenue

3.6B

Surprise %+6.4%

Beat / missBeat

Beat streak 44

Beat streak 84

Reaction

1-day stock reaction-2.7%

Implied vs actual

Implied 2.8%Actual 3.6%

Gap reaction-3.6%

Day result-6.2%

Next-day upNo

Realized / IV1.28×

Post tape

Post 5d+5.1%

Post 10d+4.9%

Post volume1.8M

Vol ×10d2.78×

Vol ×20d2.77×

Post range5.7%